China’s COVID-19 Oral Pill Gets Regulatory Approval

2022-07-27

China’s top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.

Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.

The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.

China Daily

COVID-19 oral pill

Maybe you like also

» How to Collect a Nasopharyngeal Swab Specimen for Pertussis Testing

» Whooping Cough vs. Common Cold: How to Tell the Difference

» Understanding Whooping Cough: Causes, Symptoms, and Treatment Options

» Self-Sampling for HPV Testing in Men

» Understanding the Different Types of Blood Collection Tubes

» Common Errors in Blood Collection Tube Usage and How to Avoid Them

Medico Technology Co., Ltd. is a professional manufacturer of medical supplies in China, we produce and sale nylon flocked swabs, VTM kit, saliva collection kit and CHG swab & applicator.

Address: Room 201, 301 and 401 Building A No.10, Bao long 5th Road, Tongle Community, Baolong Street, Longgang District,Shenzhen, Guangdong, China.

Web: www.medicoswab.com

Phone Number: +86 0755-28997664

Email: info@medicoswab.com